A Phase II Open-Label, Single Centre, Non-Randomised Trial of Y90-Radioembolization in Combination with Nivolumab in Asian Patients with Advanced Hepatocellular Carcinoma: An Interim Analysis

HEPATOLOGY(2018)

引用 1|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要